Home > Healthcare & Medical Devices > Cell Culture Protein Surface Coating Market
Cell Culture Protein Surface Coating Market size is expected to increase considerably from 2023 to 2032. Potential advantages of cell culture plate coating with proteins, such as improved adhesion, increased growth of primary cells, and high cell proliferation would support the growing adoption of cell culture protein surface coating.
Moreover, growing demand of the three-dimensional culture approach to model the morphological effects of oncogenesis will further drive the market expansion, as 3D cell culture collagen coating can be used to study cellular development and differentiation in 3D microenvironments. The cell culture flask coating with extracellular matrix proteins has become a common procedure across cell culture labs for use in receptor-ligand binding studies and other applications.
Increasing age-standardized mortality rates due to neurological disorders worldwide is one of the factors augmenting the cell culture protein surface coating market trends by 2032. As per the European Academy of Neurology, neurological diseases affect nearly 1 in 3 people at some point of their life. Moreover, the disorder has claimed more than 40% of the patient population over the past 30 years. Since cell culture is extensively used in 2D and 3D neuroinflammatory cell models for drug screening applications, the rising burden of nervous system diseases will push industry dynamics.
Furthermore, the high emphasis on stem cell research to replace damaged or diseased cells and lead to breakthroughs in the treatment of Parkinson’s disease and other conditions will also generate progression opportunities for the market in the coming years.
Cell culture protein surface coating industry is slated to observe slight hinderance given the rising food and fuel inflation worldwide. Higher retail inflation would affect consumer spending and confidence, negatively influencing the economic landscape. Moreover, lower capital investment by companies could lead to weaker product development in the coming years.
Based on protein source, the cell culture protein surface coating market from the synthetic protein segment will register an appreciable revenue by 2032. The segmental progress can be credited to the high suitability of cell culture vessels coated with synthetic proteins for use in serum-reduced and serum-free experiments and cultivations. Moreover, the ability of poly-amino acids to create a positive change on polystyrene and boost the availability of positively charged sites for cell binding, influencing cell behavior, will amplify the usage of synthetic proteins for cell culture surface coating.
In terms of regional purview, Europe cell culture protein surface coating market is set to grow rapidly through 2032. This progression is driven by the mounting investments in stem cell research in the region. For example, the UK Stem Cell Bank received a National Institute for Health Research grant worth over USD 1.5 million to offer regulator-ready, high-quality cell lines for use as starting materials for advanced therapies. In addition, the rising prevalence of cardiovascular diseases and the progress of regenerative medicine research, will further augment the need for cell culture and in turn, impelling the regional market forecast.
Key players in the cell culture protein surface coating market include Viogene BioTek Corporation, uVera Diagnostics, Qiagen, Sartorius Stedim Biotech, Promega Corporation, Corning Incorporated, Abcam, BioVision, Greiner Bio-One International (Greiner Group AG), Merck (E. Merck KG), Trevigen (Bio-Techne), PerkinElmer, and Thermo Fisher Scientific, among others.